Published in J Clin Endocrinol Metab on December 26, 2007
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab (2010) 1.50
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev (2013) 1.33
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci (2013) 1.17
Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell (2013) 1.07
Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl (2014) 1.05
Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol (2011) 1.03
The hypoxic testicle: physiology and pathophysiology. Oxid Med Cell Longev (2012) 1.01
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diabetes Rev (2012) 1.00
Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS Med (2011) 0.99
High serum testosterone levels are associated with excessive erythrocytosis of chronic mountain sickness in men. Am J Physiol Endocrinol Metab (2009) 0.92
Hematological changes during androgen deprivation therapy. Asian J Androl (2012) 0.91
Minireview: Nuclear receptors, hematopoiesis, and stem cells. Mol Endocrinol (2009) 0.87
Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial. Am J Physiol Endocrinol Metab (2013) 0.84
Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial. Support Care Cancer (2013) 0.83
The practical management of testosterone deficiency in men. Nat Rev Urol (2015) 0.83
Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone. Am J Physiol Endocrinol Metab (2014) 0.82
Male hormonal contraception. Virtual Mentor (2012) 0.81
Gonadal status and physical performance in older men. Aging Male (2010) 0.81
Effect of host lizard anemia on host choice and feeding rate of larval western black-legged ticks (Ixodes pacificus). Exp Appl Acarol (2013) 0.81
The association between the levels of serum ferritin and sex hormones in a large scale of Chinese male population. PLoS One (2013) 0.80
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
Serum testosterone levels and excessive erythrocytosis during the process of adaptation to high altitudes. Asian J Androl (2013) 0.79
Testosterone supplementation improves anemia in aging male mice. J Gerontol A Biol Sci Med Sci (2013) 0.79
Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Ther Adv Drug Saf (2014) 0.78
Testosterone Attenuates Age-Related Fall in Aerobic Function in Mobility Limited Older Men With Low Testosterone. J Clin Endocrinol Metab (2016) 0.78
Effects of anabolic-androgens on brain reward function. Front Neurosci (2015) 0.77
Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis. J Urol (2015) 0.77
Androgens and male aging: Current evidence of safety and efficacy. Asian J Androl (2010) 0.77
Testosterone deficiency and treatment in older men: definition, treatment, pitfalls. Asian J Androl (2010) 0.76
Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice. Chin Med J (Engl) (2016) 0.76
Testosterone deficiency in the aging male. Ther Adv Urol (2016) 0.75
Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) (2016) 0.75
Mesenteric vein thrombosis caused by secondary polycythaemia from AndroGel. BMJ Case Rep (2014) 0.75
Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases. Cardiovasc Diabetol (2009) 0.75
Therapy: Are long-acting intramuscular testosterone injections safe? Nat Rev Urol (2015) 0.75
Multiple Intussusceptions Associated with Polycythemia in an Anabolic Steroid Abuser, A Case Report and Literature Review. Ann Med Health Sci Res (2015) 0.75
Metabolic effects of polycystic ovary syndrome in adolescents. Ann Pediatr Endocrinol Metab (2015) 0.75
Testosterone induced polycythemias. Dtsch Arztebl Int (2008) 0.75
From cellular to chemical approach for acute neural and alternative options for age-induced functional diseases. World J Stem Cells (2015) 0.75
Serum Ferritin Is Inversely Correlated with Testosterone in Boys and Young Male Adolescents: A Cross-Sectional Study in Taiwan. PLoS One (2015) 0.75
Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes. Clin Endocrinol (Oxf) (2016) 0.75
A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men. Can Urol Assoc J (2014) 0.75
Gender-Specific Differences in Clinical Profile and Biochemical Parameters in Patients with Cushing's Disease: A Single Center Experience. Int J Endocrinol (2015) 0.75
Involvement of blood mononuclear cells in the infertility, age-associated diseases and cancer treatment. World J Stem Cells (2016) 0.75
The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones. Int J Endocrinol (2015) 0.75
A Case of Male Osteoporosis: A 37-Year-Old Man with Multiple Vertebral Compression Fractures. Case Rep Endocrinol (2017) 0.75
Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med (2006) 17.55
Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med (2006) 10.65
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci (2005) 3.14
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab (2004) 3.02
Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab (2001) 2.79
Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab (1997) 2.71
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab (2000) 2.68
Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab (2004) 2.47
Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab (1999) 1.84
Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta (2003) 1.81
The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1998) 1.71
Anabolic androgenic steroids in the treatment of acquired aplastic anemia. Blood (1969) 1.65
Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab (2006) 1.63
Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases. N Engl J Med (1961) 1.39
Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab (1997) 1.09
Polycythaemia as a complication of transdermal testosterone therapy. Br J Haematol (2000) 1.00
Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Acta Physiol Pharmacol Ther Latinoam (1998) 0.96
Erythropoietin and erythropoiesis in anemic man following androgens. Blood (1969) 0.94
Risks versus benefits of testosterone therapy in elderly men. Drugs Aging (1999) 0.94
Effects of various modes of androgen substitution therapy on erythropoiesis. Eur J Med Res (1997) 0.91
The mechanism of action of androgens on erythropoiesis. Ann N Y Acad Sci (1968) 0.90
Androgen and erythropoiesis: evidence for an androgen receptor in erythroblasts from human bone marrow cultures. Horm Res (1988) 0.89
Clinical applications of measurement of serum immunoreactive levels of erythropoietin. Ann N Y Acad Sci (1985) 0.84
Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. J Endocrinol (2005) 0.84
Androgen therapy in chronic renal failure. Baillieres Clin Endocrinol Metab (1998) 0.84
The effect of testosterone on erythropoietin levels in anemic patients. Blood (1968) 0.83
Androgen-induced erythrocytosis: is it erythropoietin? Am J Hematol (1999) 0.83
Increase in erythroid colony formation in rabbits following the administration of testosterone. Proc Soc Exp Biol Med (1975) 0.81
Erythropoietic mechanism of androgens: a critical review and clinical implications. Haematologica (1982) 0.81
Whole blood viscosity and haematocrit are associated with internal carotid atherosclerosis in men. Coron Artery Dis (1998) 0.81
Plasma erythropoietin levels in patients undergoing long-term hemodialysis. Arch Pathol Lab Med (1978) 0.80
Effect of nortestosterone decanoate on red cell 2,3 diphosphoglycerate and hematocrit in hemodialysis patients. Clin Pharmacol Ther (1975) 0.80
Androgen therapy in haemodialysis patients. II. Effects on red cell metabolism. Br J Haematol (1987) 0.79
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med (2012) 4.18
Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2010) 3.40
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci (2005) 3.14
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab (2004) 2.47
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One (2008) 2.32
Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 2.08
Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial. Pain (2015) 2.01
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab (2003) 1.98
Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.91
Ascertainment of Testosterone Prescribing Practices in the VA. Med Care (2015) 1.89
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology (2003) 1.74
Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab (2003) 1.74
19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo. Cancer Biol Ther (2007) 1.73
Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. Am J Cardiol (2011) 1.65
Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab (2010) 1.62
Targeting the skeletal muscle-metabolism axis in prostate-cancer therapy. N Engl J Med (2012) 1.61
Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol (2011) 1.61
Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab (2003) 1.57
Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology (2005) 1.56
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab (2002) 1.54
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51
Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab (2011) 1.50
DNA extraction procedures meaningfully influence qPCR-based mtDNA copy number determination. Mitochondrion (2009) 1.50
Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl (2003) 1.50
Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab (2010) 1.50
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss. Am J Physiol Endocrinol Metab (2008) 1.46
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Genetic determinants of serum testosterone concentrations in men. PLoS Genet (2011) 1.45
Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial. J Gerontol A Biol Sci Med Sci (2013) 1.44
Androgen supplementation in older women: too much hype, not enough data. J Am Geriatr Soc (2002) 1.43
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Testosterone and growth hormone improve body composition and muscle performance in older men. J Clin Endocrinol Metab (2009) 1.40
Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab (2006) 1.40
Tests of muscle strength and physical function: reliability and discrimination of performance in younger and older men and older men with mobility limitations. J Am Geriatr Soc (2008) 1.37
Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab (2004) 1.36
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev (2013) 1.33
Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab (2003) 1.33
The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem (2008) 1.32
Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care (2004) 1.32
Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab (2006) 1.31
Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet (2011) 1.30
Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab (2005) 1.28
Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc (2007) 1.24
Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. J Am Geriatr Soc (2008) 1.24
A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genet (2012) 1.23
Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab (2004) 1.21
The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol (2006) 1.20
The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab (2002) 1.20
Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology (2008) 1.20
Habitual physical activity levels are associated with performance in measures of physical function and mobility in older men. J Am Geriatr Soc (2010) 1.19
Understanding patient acceptance and refusal of HIV testing in the emergency department. BMC Public Health (2012) 1.17
Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab (2009) 1.16
Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study. J Clin Endocrinol Metab (2011) 1.15
Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol (2007) 1.14
Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency department. AIDS Patient Care STDS (2011) 1.14
Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc (2008) 1.13
Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol (2008) 1.12
Prevalence and correlates of unknown HIV infection among patients seeking care in a public hospital emergency department. Public Health Rep (2009) 1.10
Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci (2010) 1.09
Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell (2013) 1.07
Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods. Contemp Clin Trials (2008) 1.06
Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells. J Cell Physiol (2002) 1.06
An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int (2007) 1.05
HIV testing attitudes and practices among clinicians in the era of updated Centers for Disease Control and Prevention recommendations. J Acquir Immune Defic Syndr (2009) 1.03
Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration. Mol Cell Endocrinol (2009) 1.03
Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2012) 1.01
Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trial. J Gerontol A Biol Sci Med Sci (2010) 1.01
Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids (2009) 1.00
Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci (2009) 0.99
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci (2012) 0.96
Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: potential role of follistatin in mediating testosterone action. Mol Cell Endocrinol (2011) 0.96
The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab (2010) 0.96
Determinants of serum total and free testosterone levels in women over the age of 65 years. J Clin Endocrinol Metab (2006) 0.96
Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol (1985) (2007) 0.95
Role of myostatin in metabolism. Curr Opin Clin Nutr Metab Care (2004) 0.95
Role of follistatin in promoting adipogenesis in women. J Clin Endocrinol Metab (2009) 0.95
Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department. Acad Emerg Med (2011) 0.93
The dynamic structure of the estrogen receptor. J Amino Acids (2011) 0.92
Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol (Oxf) (2013) 0.92
Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Diabetes (2009) 0.92
Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab (2014) 0.92
Pharmacokinetics of a testosterone gel in healthy postmenopausal women. J Clin Endocrinol Metab (2005) 0.92